Cargando…
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
INTRODUCTION: Circulating tumor cells (CTCs) are commonly isolated from the blood by targeting the epithelial cell adhesion molecule (EpCAM) through positive selection. However, EpCAM can be downregulated during metastatic progression, or it can be initially not present. We designed the present pros...
Autores principales: | Lustberg, Maryam B, Balasubramanian, Priya, Miller, Brandon, Garcia-Villa, Alejandra, Deighan, Clayton, Wu, Yongqi, Carothers, Sarah, Berger, Michael, Ramaswamy, Bhuvaneswari, Macrae, Erin R, Wesolowski, Robert, Layman, Rachel M, Mrozek, Ewa, Pan, Xueliang, Summers, Thomas A, Shapiro, Charles L, Chalmers, Jeffrey J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053256/ https://www.ncbi.nlm.nih.gov/pubmed/24602188 http://dx.doi.org/10.1186/bcr3622 |
Ejemplares similares
-
Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapy
por: Garcia-Villa, Alejandra, et al.
Publicado: (2012) -
Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis
por: Wu, Yongqi, et al.
Publicado: (2016) -
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]‐Fluorothymidine Positron Emission Tomography Biomarker Study
por: Wesolowski, Robert, et al.
Publicado: (2020) -
Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer
por: Wesolowski, Robert, et al.
Publicado: (2020) -
CSF1-ETS2 Induced microRNA in Myeloid Cells Promote Metastatic Tumor Growth
por: Mathsyaraja, Haritha, et al.
Publicado: (2014)